A South Korean biotech company has filed an appeal with the Federal Court after an Ashurst partner succeeded in opposing the company’s proposed patent for a genome editing technology.
A South Korean biotech company has filed an appeal with the Federal Court after an Ashurst partner succeeded in opposing the company’s proposed patent for a genome editing technology.
For information on rights and reprints, contact subscriptions@lawyerly.com.au